HAP1, initially identified as a neuronal protein, exhibits specific binding to huntingtin (HTT). This interaction is enhanced by expanded polyglutamine repeats within HTT, potentially influencing HAP1's functional properties. Both HTT and HAP1 are implicated in intracellular trafficking, with HAP1 hypothesized to link HTT to motor proteins and/or transported cargo. HAP1 plays a role in neuronal and axonal vesicular transport, facilitating movement from early to late endocytic compartments and promoting neurite outgrowth. Mutant HTT can attenuate this vesicular transport function, mediated through interactions with microtubule-dependent transporters. HAP1 is involved in the axonal transport and activity-dependent secretion of brain-derived neurotrophic factor (BDNF), a process seemingly involving HTT, DCTN1, and a SORT1-containing complex. Furthermore, HAP1 participates in amyloid precursor protein (APP) trafficking, facilitating anterograde transport and membrane insertion, potentially reducing amyloid-beta processing. It also contributes to the synaptic delivery of GABA(A) receptors, a function dependent on the kinesin motor protein KIF5 and disrupted by HTT with expanded polyglutamine repeats. HAP1 regulates autophagosome motility by promoting efficient retrograde axonal transport. Its involvement extends to the regulation of membrane receptor recycling, degradation, and signal transduction, encompassing GABA(A) receptors, tyrosine kinase receptors, EGFR, IP3 receptor, and the androgen receptor. Additional proposed roles include the regulation of feeding behavior (via hypothalamic GABA(A) receptors), cerebellar and brainstem development (involving AHI1 and NTRK1/TrkA), postnatal neurogenesis (involving hypothalamic NTRK2/TrkB), and ITPR1/InsP3R1-mediated Ca2+ release (involving HTT and potentially the effects of mutant HTT). Through interactions with DCTN1/dynactin p150-glued and HTT, HAP1 participates in the cytoplasmic retention of REST in neurons. It may also be involved in ciliogenesis, exocytosis, and the formation of cytoplasmic inclusion bodies (STBs). In cases of anomalous TBP expression, HAP1 can sequester a subset of TBP into STBs, a process enhanced by expanded polyglutamine repeats within TBP. HAP1-containing STBs are suggested to play a protective role against neurodegeneration in Huntington's disease (HD) and spinocerebellar ataxia 17 (SCA17).